Matzdorff AC - Search Results

1

Comparison of GP IIB/IIIA inhibitors and their activity as measured by aggregometry, flow cytometry, single platelet counting, and the rapid platelet function analyzer.

Matzdorff AC, Kühnel G, Kemkes-Matthes B, Voss R. Matzdorff AC, et al. J Thromb Thrombolysis. 2001 Oct;12(2):129-39. doi: 10.1023/a:1012967320220. J Thromb Thrombolysis. 2001. PMID: 11729364

2

Upregulation of GP IIb/IIIa receptors during platelet activation: influence on efficacy of receptor blockade.

Matzdorff A, Voss R. Matzdorff A, et al. Thromb Res. 2006;117(3):307-14. doi: 10.1016/j.thromres.2005.03.007. Thromb Res. 2006. PMID: 15894353

3

Comparison of beta-thromboglobulin, flow cytometry, and platelet aggregometry to study platelet activation.

Matzdorff AC, Kemkes-Matthes B, Voss R, Pralle H. Matzdorff AC, et al. Haemostasis. 1996 Mar-Apr;26(2):98-106. doi: 10.1159/000217194. Haemostasis. 1996. PMID: 9119289

4

Quantitative assessment of platelets, platelet microparticles, and platelet aggregates with flow cytometry.

Matzdorff AC, Kühnel G, Kemkes-Matthes B, Pralle H. Matzdorff AC, et al. J Lab Clin Med. 1998 Jun;131(6):507-17. doi: 10.1016/s0022-2143(98)90059-2. J Lab Clin Med. 1998. PMID: 9626986

5

Relative and absolute changes of activated platelets, microparticles and platelet aggregates after activation in vitro.

Matzdorff AC, Berchner D, Kühnel G, Kemkes-Matthes B, Pralle H, Voss R. Matzdorff AC, et al. Haemostasis. 1998 Nov-Dec;28(6):277-88. doi: 10.1159/000022444. Haemostasis. 1998. PMID: 10461010

6

Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro.

Matzdorff AC, Kühnel G, Kemkes-Matthes B, Pralle H, Voss R, Fareed J. Matzdorff AC, et al. J Lab Clin Med. 2000 Mar;135(3):247-55. doi: 10.1067/mlc.2000.104907. J Lab Clin Med. 2000. PMID: 10711863

7

No increase in CD62P-positive single platelets after acute platelet activation in vivo.

Voss R, Morgenstern E, Waas W, Matzdorff A. Voss R, et al. Thromb Res. 2006;117(4):393-9. doi: 10.1016/j.thromres.2005.04.003. Thromb Res. 2006. PMID: 15885758 No abstract available.

8

Pharmacodynamics of two different dosing regimens of tirofiban in citrate or PPACK anticoagulated blood.

Voss R, Grebe M, Pralle H, Tillmanns H, Matzdorff A. Voss R, et al. Platelets. 2005 Dec;16(8):492-7. doi: 10.1080/09537100500129623. Platelets. 2005. PMID: 16287616 Free article.

9

Protein Z influences the prothrombotic phenotype in Factor V Leiden patients.

Kemkes-Matthes B, Nees M, Kühnel G, Matzdorff A, Matthes KJ. Kemkes-Matthes B, et al. Thromb Res. 2002 May 15;106(4-5):183-5. doi: 10.1016/s0049-3848(02)00181-0. Thromb Res. 2002. PMID: 12297123

10

Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes.

Villmow T, Kemkes-Matthes B, Matzdorff AC. Villmow T, et al. Among authors: matzdorff ac. Thromb Res. 2002 Nov 1;108(2-3):139-45. doi: 10.1016/s0049-3848(02)00354-7. Thromb Res. 2002. PMID: 12590950

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters